APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digestive System Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digestive System Drugs Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchDigestive System Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive System Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Digestive System Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive System Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive System Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Digestive System Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digestive System Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digestive System Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digestive System Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digestive System Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digestive System Drugs market include Kunshan Rotam Reddy Pharmaceuticals, Pfizer, Eli Lilly, Novartis Pharmaceuticals Corporation and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Digestive System Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digestive System Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digestive System Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Digestive System Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Digestive System Drugs Segment by Company

Kunshan Rotam Reddy Pharmaceuticals

Pfizer

Eli Lilly

Novartis Pharmaceuticals Corporation

Sanofi

Digestive System Drugs Segment by Type

Tablet

Oral

Digestive System Drugs Segment by Application

Clinics

Hospitals

Medical Center

Others

Digestive System Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Digestive System Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Digestive System Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digestive System Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Digestive System Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Digestive System Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digestive System Drugs industry.

Chapter 3: Detailed analysis of Digestive System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Digestive System Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Digestive System Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digestive System Drugs Industry Trends Table 2. Digestive System Drugs Industry Drivers Table 3. Digestive System Drugs Industry Opportunities and Challenges Table 4. Digestive System Drugs Industry Restraints Table 5. Global Digestive System Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digestive System Drugs Revenue Share by Company (2021-2026) Table 7. Global Digestive System Drugs Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Digestive System Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Digestive System Drugs Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Digestive System Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Digestive System Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Digestive System Drugs Company, Product Type & Application Table 13. Global Digestive System Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Digestive System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Table 19. Global Digestive System Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Digestive System Drugs Sales Volume by Type (2021-2026) & (K Pcs) Table 21. Global Digestive System Drugs Sales Volume by Type (2027-2032) & (K Pcs) Table 22. Global Digestive System Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Digestive System Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Digestive System Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Digestive System Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Digestive System Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Digestive System Drugs Sales Value Share by Type (2021-2026) Table 28. Global Digestive System Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinics Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Medical Center Table 32. Significant Companies of Others Table 33. Global Digestive System Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 34. Global Digestive System Drugs Sales Volume by Application (2021-2026) & (K Pcs) Table 35. Global Digestive System Drugs Sales Volume by Application (2027-2032) & (K Pcs) Table 36. Global Digestive System Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Digestive System Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Digestive System Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Digestive System Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Digestive System Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Digestive System Drugs Sales Value Share by Application (2021-2026) Table 42. Global Digestive System Drugs Sales Value Share by Application (2027-2032) Table 43. Global Digestive System Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 44. Global Digestive System Drugs Sales by Region (2021-2026) & (K Pcs) Table 45. Global Digestive System Drugs Sales Market Share by Region (2021-2026) Table 46. Global Digestive System Drugs Sales by Region (2027-2032) & (K Pcs) Table 47. Global Digestive System Drugs Sales Market Share by Region (2027-2032) Table 48. Global Digestive System Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Digestive System Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Digestive System Drugs Sales Value Share by Region (2021-2026) Table 51. Global Digestive System Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Digestive System Drugs Sales Value Share by Region (2027-2032) Table 53. Global Digestive System Drugs Market Average Price (US$/Pcs) by Region (2021-2026) Table 54. Global Digestive System Drugs Market Average Price (US$/Pcs) by Region (2027-2032) Table 55. Global Digestive System Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. Global Digestive System Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Digestive System Drugs Sales by Country (2021-2026) & (K Pcs) Table 58. Global Digestive System Drugs Sales Market Share by Country (2021-2026) Table 59. Global Digestive System Drugs Sales by Country (2027-2032) & (K Pcs) Table 60. Global Digestive System Drugs Sales Market Share by Country (2027-2032) Table 61. Global Digestive System Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Digestive System Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Digestive System Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Digestive System Drugs Sales Value Market Share by Country (2027-2032) Table 65. Kunshan Rotam Reddy Pharmaceuticals Company Information Table 66. Kunshan Rotam Reddy Pharmaceuticals Business Overview Table 67. Kunshan Rotam Reddy Pharmaceuticals Digestive System Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 68. Kunshan Rotam Reddy Pharmaceuticals Digestive System Drugs Product Portfolio Table 69. Kunshan Rotam Reddy Pharmaceuticals Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Digestive System Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 73. Pfizer Digestive System Drugs Product Portfolio Table 74. Pfizer Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Digestive System Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. Eli Lilly Digestive System Drugs Product Portfolio Table 79. Eli Lilly Recent Development Table 80. Novartis Pharmaceuticals Corporation Company Information Table 81. Novartis Pharmaceuticals Corporation Business Overview Table 82. Novartis Pharmaceuticals Corporation Digestive System Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. Novartis Pharmaceuticals Corporation Digestive System Drugs Product Portfolio Table 84. Novartis Pharmaceuticals Corporation Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Digestive System Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Sanofi Digestive System Drugs Product Portfolio Table 89. Sanofi Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Digestive System Drugs Distributors List Table 93. Digestive System Drugs Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Digestive System Drugs Product Image Figure 2. Global Digestive System Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Digestive System Drugs Sales (2021-2032) & (K Pcs) Figure 5. Global Digestive System Drugs Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Digestive System Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Image Figure 11. Global Digestive System Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 12. Global Digestive System Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Digestive System Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Digestive System Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Digestive System Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Digestive System Drugs Sales Value Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospitals Image Figure 19. Medical Center Image Figure 20. Others Image Figure 21. Global Digestive System Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 22. Global Digestive System Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Digestive System Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Digestive System Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Digestive System Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Digestive System Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Digestive System Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 28. Global Digestive System Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Digestive System Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Digestive System Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Digestive System Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Digestive System Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Digestive System Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Digestive System Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Digestive System Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Digestive System Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Digestive System Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Digestive System Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Digestive System Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Digestive System Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Digestive System Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral
Applications
  • Clinics
  • Hospitals
  • Medical Center
  • Others
Companies covered
  • Kunshan Rotam Reddy Pharmaceuticals
  • Pfizer
  • Eli Lilly
  • Novartis Pharmaceuticals Corporation
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Digestive System Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Digestive System Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Digestive System Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Digestive System Drugs Market Dynamics
  1. 2.1 Digestive System Drugs Industry Trends
  2. 2.2 Digestive System Drugs Industry Drivers
  3. 2.3 Digestive System Drugs Industry Opportunities and Challenges
  4. 2.4 Digestive System Drugs Industry Restraints
3 Digestive System Drugs Market by Company
  1. 3.1 Global Digestive System Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Digestive System Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Digestive System Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Digestive System Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Digestive System Drugs Company Ranking (2024-2026)
  6. 3.6 Global Digestive System Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Digestive System Drugs Company Product Type and Application
  8. 3.8 Global Digestive System Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Digestive System Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Digestive System Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Digestive System Drugs Market by Type
  1. 4.1 Digestive System Drugs Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral
  4. 4.2 Global Digestive System Drugs Sales Volume by Type
  5. 4.2.1 Global Digestive System Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digestive System Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Digestive System Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Digestive System Drugs Sales Value by Type
  9. 4.3.1 Global Digestive System Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Digestive System Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Digestive System Drugs Sales Value Share by Type (2021-2032)
5 Digestive System Drugs Market by Application
  1. 5.1 Digestive System Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Medical Center
  5. 5.1.4 Others
  6. 5.2 Global Digestive System Drugs Sales Volume by Application
  7. 5.2.1 Global Digestive System Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Digestive System Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Digestive System Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Digestive System Drugs Sales Value by Application
  11. 5.3.1 Global Digestive System Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Digestive System Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Digestive System Drugs Sales Value Share by Application (2021-2032)
6 Digestive System Drugs Regional Sales and Value Analysis
  1. 6.1 Global Digestive System Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digestive System Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Digestive System Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Digestive System Drugs Sales by Region (2027-2032)
  5. 6.3 Global Digestive System Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Digestive System Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Digestive System Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Digestive System Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Digestive System Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Digestive System Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Digestive System Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Digestive System Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Digestive System Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Digestive System Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Digestive System Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Digestive System Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Digestive System Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Digestive System Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Digestive System Drugs Sales Value Share by Country, 2025 VS 2032
7 Digestive System Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Digestive System Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digestive System Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Digestive System Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Digestive System Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Digestive System Drugs Sales by Country (2027-2032)
  6. 7.4 Global Digestive System Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Digestive System Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Digestive System Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Digestive System Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Digestive System Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Digestive System Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Digestive System Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Digestive System Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Digestive System Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Digestive System Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Digestive System Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Digestive System Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Digestive System Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Digestive System Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Digestive System Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Digestive System Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Digestive System Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Digestive System Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Digestive System Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Digestive System Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Digestive System Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Digestive System Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Digestive System Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Digestive System Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Digestive System Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Digestive System Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Digestive System Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Digestive System Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Digestive System Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Digestive System Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Digestive System Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Digestive System Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Digestive System Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kunshan Rotam Reddy Pharmaceuticals
  2. 8.1.1 Kunshan Rotam Reddy Pharmaceuticals Company Information
  3. 8.1.2 Kunshan Rotam Reddy Pharmaceuticals Business Overview
  4. 8.1.3 Kunshan Rotam Reddy Pharmaceuticals Digestive System Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kunshan Rotam Reddy Pharmaceuticals Digestive System Drugs Product Portfolio
  6. 8.1.5 Kunshan Rotam Reddy Pharmaceuticals Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Digestive System Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Digestive System Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Digestive System Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Digestive System Drugs Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Novartis Pharmaceuticals Corporation
  20. 8.4.1 Novartis Pharmaceuticals Corporation Company Information
  21. 8.4.2 Novartis Pharmaceuticals Corporation Business Overview
  22. 8.4.3 Novartis Pharmaceuticals Corporation Digestive System Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Pharmaceuticals Corporation Digestive System Drugs Product Portfolio
  24. 8.4.5 Novartis Pharmaceuticals Corporation Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Digestive System Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Digestive System Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Digestive System Drugs Value Chain Analysis
  2. 9.1.1 Digestive System Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Digestive System Drugs Sales Mode & Process
  6. 9.2 Digestive System Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Digestive System Drugs Distributors
  9. 9.2.3 Digestive System Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst